Cancer Biology & Therapy

Papers
(The H4-Index of Cancer Biology & Therapy is 22. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)
ArticleCitations
Correction93
Phase I double-blind, placebo-controlled trial of dolcanatide (SP-333) 27 mg to explore colorectal bioactivity in healthy volunteers60
DDX24 regulates the chemosensitivity of hepatocellular carcinoma to sorafenib via mediating the expression of SNORA1851
Loss of ubiquitin-specific peptidase 18 destabilizes 14-3-3ζ protein and represses lung cancer metastasis42
CPT1A mediates the succinylation of SP5 which activates transcription of PDPK1 to promote the viability and glycolysis of prostate cancer cells41
Correction39
Molecular profiles of different PD-L1 expression in patients with esophageal squamous cell carcinoma39
Tripartite motif-containing protein 50 suppresses triple-negative breast cancer progression by regulating the epithelial–mesenchymal transition34
Evaluating massage therapy for radiation-induced fibrosis in rats: preliminary findings and palpation results32
miRNA-660-3p inhibits malignancy in glioblastoma via negative regulation of APOC1-TGFβ2 signaling pathway31
Immunotherapy resistance in solid tumors: mechanisms and potential solutions30
Clinical application of molecular residual disease detection by circulation tumor DNA in solid cancers and a comparison of technologies: review article30
Clinical and biological determinants of circulating tumor DNA detection and prognostication using a next-generation sequencing panel assay30
Partial treatment response to capmatinib in MET-amplified metastatic intrahepatic cholangiocarcinoma: case report & review of literature28
Targeting gastrointestinal cancers with chimeric antigen receptor (CAR)-T cell therapy27
Silencing ZIC5 suppresses glycolysis and promotes disulfidptosis in lung adenocarcinoma cells25
Linoleic acid exhibits anti-proliferative and anti-invasive activities in endometrial cancer cells and a transgenic model of endometrial cancer24
GdX inhibits the occurrence and progression of breast cancer by negatively modulating the activity of STAT324
MiR-128-1-5p inhibits cell proliferation and induces cell apoptosis via targeting PRKCQ in colorectal cancer24
SATB1 mediated tumor colonization and β-catenin nuclear localization are associated with colorectal cancer progression23
Requirement for containing etoposide in the initial treatment of lymphoma associated hemophagocytic lymphohistiocytosis23
Small extracellular vesicle-mediated ITGB6 siRNA delivery downregulates the αVβ6 integrin and inhibits adhesion and migration of recipient prostate cancer cells23
Bibliometric analysis of autophagy in the diagnosis and treatment of osteosarcoma: a bibliometric analysis (2007–2023)22
LINC01060 knockdown inhibits osteosarcoma cell malignant behaviors in vitro and tumor growth and metastasis in vivo through the PI3K/Akt s22
0.038814067840576